Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HERBALIFE LTD. Director's Dealing 2022

Dec 27, 2022

32337_dirs_2022-12-27_6617841f-032e-4149-ad06-0e418b4067b3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HERBALIFE NUTRITION LTD. (HLF)
CIK: 0001180262
Period of Report: 2022-12-22

Reporting Person: JOHNSON MICHAEL (Director, Chairman & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-12-22 Common Stock A 346020 $0.00 Acquired 621082 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-12-22 Stock Appreciation Rights $14.45 A 783699 Acquired 2032-12-22 Common Stock (783699) Direct

Footnotes

F1: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan. The RSUs will vest 50% on December 22, 2023, and December 22, 2024, subject to certain terms and conditions of his continuing service as CEO and/or member of the Board.

F2: On December 22, 2022, the reporting person was granted 783,699 SARs. These SARs will vest 100% on December 22, 2024, subject to certain terms and conditions of his continuing service as CEO and/or member of the Board.